<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7424">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03010280</url>
  </required_header>
  <id_info>
    <org_study_id>INMUNOBAR 2016/1</org_study_id>
    <nct_id>NCT03010280</nct_id>
  </id_info>
  <brief_title>Effect of Immunonutrition on Septic Complications After Roux-en-Y Gastric Bypass</brief_title>
  <official_title>Effect of Immunonutrition on Septic Complications and Analytical Acute Phase Reactants After Roux-en-Y Gastric Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective randomized clinical trial of all the patients undergoing Roux - en-Y gastric
      bypass will be performed. Patients will be randomly assigned into 2 groups: those patients
      receiving a preoperative balanced energy high-protein formula (group 1) and those receiving
      preoperative Immunonutrition (group 2). Preoperative weight loss, postoperative septic
      complications and analytical acute phase reactants will be investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized clinical trial of all the patients undergoing Roux - en-Y gastric
      bypass will be performed. Patients will be randomly assigned into 2 groups: those patients
      receiving a preoperative balanced energy high-protein formula (group 1) and those receiving
      preoperative Immunonutrition (group 2). Postoperative septic complications (anastomotic leak
      and organ/space SSI) and analytical acute phase reactants (white blood cell count and C
      reactive protein) will be investigated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Septic complications</measure>
    <time_frame>During the first 30 days postoperatively</time_frame>
    <description>Anastomotic leak and organ/space SSI determined during 30 days postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute phase reactants</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>The elevation of C reactive protein and white blood cell count will be determined in a blood sample extracted 24 hours after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Immunonutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving a preoperative balanced energy high-protein formula, enriched with Omega - 3 fatty acids (Immunonutrition formula)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High protein formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving a preoperative balanced energy high-protein formula, without including Omega - 3 fatty acids</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Immunonutrition</intervention_name>
    <description>Balanced high-protein formula enriched with Omega-3 fatty acids. 200 ml of formula every 8 hours during 10 days preoperatively</description>
    <arm_group_label>Immunonutrition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Balanced high-protein formula</intervention_name>
    <description>Balanced high-protein formula, without Omega-3 fatty acids. 200 ml of formula every 8 hours during 10 days preoperatively</description>
    <arm_group_label>High protein formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  body mass index (BMI)&gt;40 kg/m2

          -  BMI&gt;35 kg/m2 with the presence of comorbidities associated to obesity

          -  Patients undergoing Roux-en-Y gastric bypass as bariatric procedure

        Exclusion Criteria:

          -  Patients undergoing other bariatric techniques different than Roux-en-Y gastric
             bypass

          -  gastroesophageal reflux

          -  patients with uncontrolled psychiatric disorders

          -  active infections or malignancies

          -  any other concomitant pathology considered as a contraindication for bariatric
             surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaime Ruiz-Tovar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundacion Jimenez Diaz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucia llanos, MD, PhD</last_name>
    <email>lucia.llanos@fjd.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Ruiz-Tovar</last_name>
      <email>jruiztovar@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 3, 2017</lastchanged_date>
  <firstreceived_date>January 3, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
